SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/22 Bionano Genomics, Inc. 8-K:5 6/09/22 11:211K Edgarfilings Ltd. |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 36K 6: R1 Document and Entity Information HTML 52K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- brhc10038653_8k_htm XML 20K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.DEF XBRL Definitions -- bngo-20220609_def XML 50K 4: EX-101.LAB XBRL Labels -- bngo-20220609_lab XML 75K 5: EX-101.PRE XBRL Presentations -- bngo-20220609_pre XML 54K 2: EX-101.SCH XBRL Schema -- bngo-20220609 XSD 15K 10: JSON XBRL Instance as JSON Data -- MetaLinks 15± 22K 11: ZIP XBRL Zipped Folder -- 0001140361-22-022621-xbrl Zip 14K
i Delaware
|
i 26-1756290
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
i 9540 Towne Centre Drive, i Suite 100
i San Diego, i California
|
i 92121
|
|
(Address of principal executive offices)
|
(Zip Code)
|
i ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
i ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
i ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
i ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
i Common Stock, $0.0001 par value per share
|
i BNGO
|
i The Nasdaq Stock Market LLC
|
||
i Warrants to purchase Common Stock
|
i BNGOW
|
i The Nasdaq Stock Market LLC
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
Name
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
|||
64,165,380
|
11,997,274
|
74,272,962
|
||||
David L. Barker, Ph.D.
|
66,143,604
|
10,019,050
|
74,272,962
|
|||
Vincent J. Wong, J.D., M.B.A.
|
71,364,011
|
4,798,643
|
74,272,962
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
|||
44,243,164
|
29,288,589
|
2,630,901
|
74,272,962
|
1 Year
|
2 Years
|
3 Years
|
Abstentions
|
|||
65,130,701
|
3,031,399
|
4,575,295
|
3,425,259
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
|||
144,242,145
|
3,644,872
|
2,548,599
|
—
|
Bionano Genomics, Inc.
|
||
Date: June 10, 2021
|
By:
|
|
President and Chief Executive Officer
|
||
(Principal Executive Officer)
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
12/31/22 | ||||
Filed on: | 6/10/22 | |||
For Period end: | 6/9/22 | 4, DEF 14A | ||
4/12/22 | ||||
6/10/21 | 4, 8-K, DEF 14A | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/09/23 Bionano Genomics, Inc. POSASR 3/09/23 5:809K Broadridge Fin’l So… Inc |